ShareValue scores for 600538.SHG: Valuation 36, Quality 14, Growth 46, Health 46.

600538.SHG
SSE

Beihai Gofar Marine Biological Industry Co Ltd

CN¥5.32(+6.83%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-8% to 12%
Valuation
36
Overvalued
Price vs Value
Quality
14
Weak
Business Strength
Growth
46
Moderate
Revenue & Earnings
Health
46
Moderate
Financial Stability
Momentum
20
Bearish
Price Trend

Company Details

About

Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, distributes pharmaceutical products in China. It operates through Pharmaceutical Distribution; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails pharmaceutical products through hospitals, clinics, other medical institutions, pharmacies, health centers, clinics, directly operated stores, general agents, distributors, and allocations. It also provides pearl eye drops, pearl powder, and pearl layer powder under the Haibao brand; brand gastrointestinal granules, honeysuckle oral solution, and children's syrup under the Guofa brand; and traumatic injury medicated wine, and sea snake medicated wine under the Haima brand. In addition, the company produces and sells forensic DNA testing equipment, reagents, and consumables; and provides technical services, including DNA testing services. Further, it engages in culture and arts activities; and provision of technical services. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in June 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was incorporated in 1993 and is headquartered in Beihai, China. Address: No.3 Beibuwan Middle Road, Beihai, China, 536000

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026